HU0202548D0 - - Google Patents

Info

Publication number
HU0202548D0
HU0202548D0 HU0202548A HUP0202548A HU0202548D0 HU 0202548 D0 HU0202548 D0 HU 0202548D0 HU 0202548 A HU0202548 A HU 0202548A HU P0202548 A HUP0202548 A HU P0202548A HU 0202548 D0 HU0202548 D0 HU 0202548D0
Authority
HU
Hungary
Application number
HU0202548A
Other languages
Hungarian (hu)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of HU0202548D0 publication Critical patent/HU0202548D0/hu
Publication of HUP0202548A2 publication Critical patent/HUP0202548A2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HU0202548A 2001-08-01 2002-07-31 Faggyútermelés gátlásánál alkalmazható viaszészter- és koleszterilészter-szintézist gátló kettős inhibitorok és ezeket tartalmazó gyógyszerkészítmények HUP0202548A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30933601P 2001-08-01 2001-08-01

Publications (2)

Publication Number Publication Date
HU0202548D0 true HU0202548D0 (US07582779-20090901-C00044.png) 2002-10-28
HUP0202548A2 HUP0202548A2 (hu) 2003-02-28

Family

ID=23197778

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202548A HUP0202548A2 (hu) 2001-08-01 2002-07-31 Faggyútermelés gátlásánál alkalmazható viaszészter- és koleszterilészter-szintézist gátló kettős inhibitorok és ezeket tartalmazó gyógyszerkészítmények

Country Status (11)

Country Link
US (1) US20030134898A1 (US07582779-20090901-C00044.png)
EP (1) EP1281399A3 (US07582779-20090901-C00044.png)
JP (1) JP2003104878A (US07582779-20090901-C00044.png)
KR (1) KR20030013289A (US07582779-20090901-C00044.png)
CN (1) CN1404829A (US07582779-20090901-C00044.png)
CA (1) CA2395006A1 (US07582779-20090901-C00044.png)
HU (1) HUP0202548A2 (US07582779-20090901-C00044.png)
IL (1) IL150918A0 (US07582779-20090901-C00044.png)
NZ (1) NZ520487A (US07582779-20090901-C00044.png)
PL (1) PL355281A1 (US07582779-20090901-C00044.png)
ZA (1) ZA200206032B (US07582779-20090901-C00044.png)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
JP2007508291A (ja) * 2003-10-09 2007-04-05 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 皮脂産生を減少させるためのマロンアミド誘導体を含んでなる医薬組成物
JP5197016B2 (ja) 2004-12-23 2013-05-15 デシファラ ファーマスーティカルズ, エルエルシー 酵素モジュレータ及び治療
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
MX2009011343A (es) 2007-04-20 2009-11-05 Deciphera Pharmaceuticals Llc Inhibidores quinasa utiles para el tratamiento de enfermedades mieloproliferativas y otras enfermedades proliferativas.
EA201170627A1 (ru) 2008-10-29 2011-10-31 ДЕСИФЕРА ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Циклопропанамиды и аналоги, проявляющие противораковые и антипролиферативные активности
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
BR112018016671A2 (pt) 2016-02-16 2018-12-26 The University Of Queensland sulfonilureias e compostos relacionados e uso do mesmo
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
CA3089630A1 (en) 2018-01-31 2019-08-08 Deciphera Pharmaceuticals, Llc Combination therapy for the treatment of mastocytosis
SG11202007198WA (en) 2018-01-31 2020-08-28 Deciphera Pharmaceuticals Llc Combination therapy for the treatment of gastrointestinal stromal tumors
CR20210139A (es) * 2018-08-15 2021-06-24 Inflazome Ltd Compuestos de sulfonamidaurea novedosos
US12054461B2 (en) 2019-06-12 2024-08-06 NodThera Limited Sulfonylurea derivatives and uses thereof
MX2022001863A (es) 2019-08-12 2022-05-30 Deciphera Pharmaceuticals Llc Metodos para tratar los tumores del estroma gastrointestinal.
TW202122082A (zh) 2019-08-12 2021-06-16 美商迪賽孚爾製藥有限公司 治療胃腸道基質瘤方法
KR20220123058A (ko) 2019-12-30 2022-09-05 데시페라 파마슈티칼스, 엘엘씨. 1-(4-브로모-5-(1-에틸-7-(메틸아미노)-2-옥소-1,2-디히드로-1,6-나프티리딘-3-일)-2-플루오로페닐)-3-페닐우레아의 조성물
DK4084778T3 (da) 2019-12-30 2023-12-11 Deciphera Pharmaceuticals Llc Amorfe kinaseinhibitorformuleringer og fremgangsmåder til anvendelse deraf
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716175A (en) * 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
US5254715A (en) * 1990-11-07 1993-10-19 Warner-Lambert Company Aminosulfonyl carbamates
US5214206A (en) * 1990-11-07 1993-05-25 Warner-Lambert Company Aminosulfonyl urea acat inhibitors
US5198466A (en) * 1990-11-09 1993-03-30 Warner-Lambert Company Oxysulfonyl urea acat inhibitors
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
US6133326A (en) * 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
ES2239145T3 (es) * 2000-02-02 2005-09-16 Warner-Lambert Company Llc Inhibidor doble de la sintesis de ester de colesterilo y de ester de cera avasimibe para el tratamiento de trastornos de la glandula sebacea.
US6514489B1 (en) * 2000-06-30 2003-02-04 Medicis Pharmaceutical Corp. Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
US6852738B2 (en) * 2001-01-30 2005-02-08 Merck & Co., Inc. Acyl sulfamides for treatment of obesity, diabetes and lipid disorders

Also Published As

Publication number Publication date
CN1404829A (zh) 2003-03-26
EP1281399A3 (en) 2004-02-11
US20030134898A1 (en) 2003-07-17
ZA200206032B (en) 2004-02-10
IL150918A0 (en) 2003-02-12
KR20030013289A (ko) 2003-02-14
JP2003104878A (ja) 2003-04-09
CA2395006A1 (en) 2003-02-01
EP1281399A2 (en) 2003-02-05
NZ520487A (en) 2004-03-26
HUP0202548A2 (hu) 2003-02-28
PL355281A1 (en) 2003-02-10

Similar Documents

Publication Publication Date Title
BE2022C531I2 (US07582779-20090901-C00044.png)
BE2022C502I2 (US07582779-20090901-C00044.png)
BE2022C547I2 (US07582779-20090901-C00044.png)
BE2017C055I2 (US07582779-20090901-C00044.png)
BE2017C051I2 (US07582779-20090901-C00044.png)
BE2017C032I2 (US07582779-20090901-C00044.png)
BE2016C051I2 (US07582779-20090901-C00044.png)
BE2015C046I2 (US07582779-20090901-C00044.png)
BE2014C052I2 (US07582779-20090901-C00044.png)
BE2014C036I2 (US07582779-20090901-C00044.png)
BE2014C026I2 (US07582779-20090901-C00044.png)
BE2017C050I2 (US07582779-20090901-C00044.png)
BE2014C004I2 (US07582779-20090901-C00044.png)
BE2014C006I2 (US07582779-20090901-C00044.png)
BE2011C034I2 (US07582779-20090901-C00044.png)
BE2007C047I2 (US07582779-20090901-C00044.png)
AU2002307149A8 (US07582779-20090901-C00044.png)
BRPI0209186B1 (US07582779-20090901-C00044.png)
BE2016C021I2 (US07582779-20090901-C00044.png)
BE2014C008I2 (US07582779-20090901-C00044.png)
BRPI0204884A2 (US07582779-20090901-C00044.png)
CH1379220H1 (US07582779-20090901-C00044.png)
BE2017C059I2 (US07582779-20090901-C00044.png)
BRPI0101486B8 (US07582779-20090901-C00044.png)
BE2012C051I2 (US07582779-20090901-C00044.png)

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees